Multifunctional Bismuth Nanoplatforms Augment Radioactive Iodine Therapy in Anaplastic Thyroid Cancer
Bi@Digoxin significantly enhances the therapeutic efficacy of RAI, offering a novel synergistic treatment strategy for ATC that combines biosafety and scalable production, with significant potential for clinical translation.
Authors
- Ke Yang (ORCID: https://orcid.org/0000-0003-4508-0641)
- Tong Liu (ORCID: https://orcid.org/0000-0001-9234-1328)
- Yanzhen Zheng
- Ye Yang (ORCID: https://orcid.org/0000-0002-0144-8339)
- Yan Liu
- Liya Gu
- Xijie Qu
- Yiqian Liang
- Jing Zhang
- Xinyuan Wei
- Yu Wang
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2026-01-01
- DOI
- https://doi.org/10.2147/ijn.s561413
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00